21ADispensed Price for RPBS Schedule Pharmaceutical benefits

21A  Dispensed Price for RPBS Schedule Pharmaceutical benefits

 (1) The Commission is to decide the dispensed price for Pharmaceutical benefits included in the RPBS Schedule and the Department is to notify a dispensed price decided by the Commission.

Note (1): in practice a delegate of the Commission could decide the dispensed price.

Note (3): sections 4 and 5 explain the process of notification for the purposes of the Scheme.

 (2) The dispensed price in (1) is to be comprised of:

 (a) the ex manufacturer price – being the price the Commission and the responsible person for the brand of the Pharmaceutical benefit have agreed, by reference to the quantity of the Pharmaceutical benefit, is to be the price at which the manufacturer sells the Pharmaceutical benefit in the context of the Scheme (approved ex manufacturer price); and

Note: in practice a delegate of the Commission could enter into the agreement.

 (b) the following amounts worked out as if the Pharmaceutical benefit is included in the PBS and the amount worked out under the PBS and the Eighth Community Pharmacy Agreement except that the approved ex manufacturer price is ascertained under the Scheme:

 (i) the wholesale mark‑up – being the mark‑up on the approved ex manufacturer price of a ready‑prepared Pharmaceutical benefit (approved wholesale price);

 (ii) the administration, handling and infrastructure fee;

Note: previously this fee was known as the pharmacy mark‑up.

 (iii) the dispensing fee (for a ready‑prepared Pharmaceutical benefit or a extemporaneously‑prepared Pharmaceutical benefit (as the case may be));

 (iv) any dangerous drug fee (for a ready‑prepared Pharmaceutical benefit).

Note: see clause 3 (Commonwealth Price) of the Eighth Community Pharmacy Agreement for the amounts mentioned above.